- Home
- STC vs BEAM Comparison
STC vs BEAM Comparison
Compare STC & BEAM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- STC
- BEAM
- Stock Information
- Founded
- STC 1893
- BEAM 2017
- Country
- STC United States
- BEAM United States
- Employees
- STC N/A
- BEAM N/A
- Industry
- STC Specialty Insurers
- BEAM Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- STC Finance
- BEAM Health Care
- Exchange
- STC Nasdaq
- BEAM Nasdaq
- Market Cap
- STC 2.0B
- BEAM 1.9B
- IPO Year
- STC N/A
- BEAM 2020
- Fundamental
- Price
- STC $65.88
- BEAM $24.70
- Analyst Decision
- STC Buy
- BEAM Buy
- Analyst Count
- STC 3
- BEAM 10
- Target Price
- STC $80.33
- BEAM $47.67
- AVG Volume (30 Days)
- STC 171.5K
- BEAM 1.1M
- Earning Date
- STC 02-05-2025
- BEAM 02-25-2025
- Dividend Yield
- STC 2.90%
- BEAM N/A
- EPS Growth
- STC 66.11
- BEAM N/A
- EPS
- STC 2.12
- BEAM N/A
- Revenue
- STC $2,408,952,800.00
- BEAM $349,643,000.00
- Revenue This Year
- STC N/A
- BEAM N/A
- Revenue Next Year
- STC $15.46
- BEAM $10.82
- P/E Ratio
- STC $31.81
- BEAM N/A
- Revenue Growth
- STC 3.34
- BEAM 328.73
- 52 Week Low
- STC $56.16
- BEAM $20.84
- 52 Week High
- STC $78.44
- BEAM $49.50
- Technical
- Relative Strength Index (RSI)
- STC 29.62
- BEAM 41.30
- Support Level
- STC $68.11
- BEAM $24.96
- Resistance Level
- STC $70.58
- BEAM $29.52
- Average True Range (ATR)
- STC 1.85
- BEAM 1.64
- MACD
- STC -0.70
- BEAM -0.51
- Stochastic Oscillator
- STC 0.37
- BEAM 9.71
About STC Stewart Information Services Corporation
Stewart Information Services Corp is a customer-focused, title insurance and real estate services company offering products and services to home buyers and sellers, mortgage lenders and servicers, attorneys, and home builders. It has three operating segments; Title insurance and related services which generates key revenue, includes the functions of searching, examining, closing, and insuring the condition of the title to real property. It also includes home and personal insurance services, Real estate solutions segment supports the real estate mortgage industry by providing appraisal management services, online notarization and closing solutions, credit, and real estate information services, search and valuation services. Corporate and other segment is comprised of parent holding company.
About BEAM Beam Therapeutics Inc.
Beam Therapeutics Inc is a biotechnology company engaged in creating genetic medicines based on its base editing technology. This technology enables a new class of genetic medicines that targets a single base in the genome without making a double-stranded break in the DNA. The company's portfolio comprises Gene Correction, Gene Modification, Gene Activation, Gene Silencing, and Multiplex Editing. The company's pipeline programs consist of BEAM-101, ESCAPE, BEAM-302, BEAM-301, and BEAM-201.